[Evidence-based medicine: Analysis of the randomized trial "imiquimod vs. surgery for basal cell carcinoma"]

[Article in French]

B Guillot¹

Affiliations

¹ Département de dermatologie, hôpital Saint-Eloi, CHU de Montpellier, rue A.-Fliche, 34295 Montpellier cedex 5, France. Electronic address: b-guillot@chu-montpellier.fr.

Comment

[Article in French]

B Guillot. Ann Dermatol Venereol. 2015 May.

. 2015 May;142(5):369-70.

doi: 10.1016/j.annder.2015.01.008. Epub 2015 Mar 3.

B Guillot¹

¹ Département de dermatologie, hôpital Saint-Eloi, CHU de Montpellier, rue A.-Fliche, 34295 Montpellier cedex 5, France. Electronic address: b-guillot@chu-montpellier.fr.

No abstract available

Comment on

Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, Williams HC; Surgery versus Imiquimod for Nodular Superficial basal cell carcinoma (SINS) study group. Bath-Hextall F, et al. Lancet Oncol. 2014 Jan;15(1):96-105. doi: 10.1016/S1470-2045(13)70530-8. Epub 2013 Dec 11. Lancet Oncol. 2014. PMID: 24332516 Clinical Trial.